History | Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 179 KB)

Published:

26 October 2016

Final appraisal determination

Final appraisal determination
Committee papers (PDF 1.34 MB)

Published:

22 September 2016
Committee papers Committee presentation (PDF 287 KB)

Published:

22 September 2016
Final appraisal determination document (PDF 343 KB)

Published:

22 September 2016

Draft guidance

Draft guidance
Appraisal consultation document (PDF 299 KB)

Published:

12 July 2016
Committee papers (PDF 8.72 MB)

Published:

12 July 2016
Committee papers Committee meeting presentation (PDF 493 KB)

Published:

12 July 2016

Invitation to participate

Final scope (PDF 121 KB)

Published:

14 January 2016
Final matrix (PDF 38 KB)

Published:

14 January 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 332 KB)

Published:

14 January 2016
Equality Impact Assessment (Guidance development) (PDF 180 KB)

Published:

14 January 2016

Draft scope for consultation (pre-referral) January 2015

Draft scope for consultation (pre-referral) January 2015
Draft scope for consultation (pre-referral) January 2015 (PDF 127 KB)

Published:

21 July 2015

Provisional matrix (pre-referral) January 2015

Provisional matrix (pre-referral) January 2015
Provisional matrix (pre-referral) January 2015 (PDF 39 KB)

Published:

21 July 2015